FOREIGN BULK PLANT INSPECTIONS HAVE 17% cGMP NON-COMPLIANCE RATE; INSPECTIONS RESULTING IN FDA LETTER RANGE FROM 5% IN ITALY TO 33% IN SWITZERLAND
Executive Summary
Inspections of active pharmaceutical ingredient manufacturers resulted in current Good Manufacturing Practices non-compliance letters from FDA in 17% of cases over a two year period.